Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$0.7 - $0.98 $1,225 - $1,715
-1,750 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$0.6 - $1.26 $1,050 - $2,205
1,750 New
1,750 $1,000

Others Institutions Holding NWBO

About NORTHWEST BIOTHERAPEUTICS INC


  • Ticker NWBO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,037,230,016
  • Market Cap $290M
  • Description
  • Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...
More about NWBO
Track This Portfolio

Track Cassady Schiller Wealth Management, LLC Portfolio

Follow Cassady Schiller Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cassady Schiller Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cassady Schiller Wealth Management, LLC with notifications on news.